Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Envi™-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke

NCT05107206 is registered in ClinicalTrials.gov with NeuroVasc Technologies as lead sponsor.

NCT NCT05107206
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05107206 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Envi™-SR Randomized Controlled Trial for Endovascular Treatment of Ischemic Stroke
Lead sponsor
NeuroVasc Technologies
Phase
Not applicable
Overall status
Terminated
Start date
June 23, 2022
Completion date
January 27, 2025
Enrollment
12 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke